Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.
- Authors
- March, John S; Franklin, Martin E; Leonard, Henrietta; Garcia, Abbe; Moore, Phoebe; Freeman, Jennifer; Foa, Edna
- Year
- 2007
- Journal
- Biological psychiatry
- PMID
- 17241830
- DOI
- 10.1016/j.biopsych.2006.09.035
BACKGROUND: The presence of a comorbid tic disorder may predict a poorer outcome in the acute treatment of pediatric obsessive-compulsive disorder (OCD). METHODS: Using data from the National Institute of Mental Health (NIMH)-funded Pediatric OCD Treatment Study (POTS) that compared cognitive-behavior therapy (CBT), medical management with sertraline (SER), and the combination of CBT and SER (COMB), to pill placebo (PBO) in children and adolescents with OCD, we asked whether the presence of a comorbid tic disorder influenced symptom reduction on the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) after 12 weeks of treatment. RESULTS: Fifteen percent (17 of 112) of patients exhibited a comorbid tic disorder. In patients without tics, results replicated previously published intent-to-treat outcomes: COMB > CBT > SER > PBO. In patients with a comorbid tic disorder, SER did not differ from PBO, while COMB remained superior to CBT and CBT remained superior to PBO. CONCLUSIONS: In contrast to CBT outcomes, which are not differentially impacted, tic disorders appear to adversely impact the outcome of medication management of pediatric OCD. Children and adolescents with obsessive-compulsive disorder and a comorbid tic disorder should begin treatment with cognitive-behavior therapy alone or the combination of cognitive-behavior therapy plus a serotonin reuptake inhibitor.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Tics and Tic-Like Phenomena as Compulsive Acts. | Grippe T et al. | β | 2026 | β |
| Efficacy of a parent-based treatment for children and adolescents with obsessive-compulsive disorder: Protocol of a multiple baseline, single-case experimental design study. | Veeger JDK et al. | β | 2025 | β |
| Pharmacotherapy for Tourette Syndrome. | Jurgen BO et al. | β | 2025 | β |
| Systematic Review and Meta-Analysis of Individual Participant Data: Randomized, Placebo-Controlled Trials of Selective Serotonin Reuptake Inhibitors for Pediatric Obsessive-Compulsive Disorder. | Cohen SE et al. | β | 2025 | β |
| Chronic Tic Disorders in Youth: Clinical Phenotypes and Response to Pharmacological Treatment with Aripiprazole. | Falcone F et al. | β | 2024 | β |
| Efficacy of pharmacological treatment in OCD comorbid with tic disorder: Systematic review and meta-analysis. | Jalenques I et al. | β | 2024 | β |
| Treatment of Obsessive-Compulsive Disorder in Children and Youth: A Meta-Analysis. | Steele DW et al. | β | 2024 | β |
| From the Editor's Desk: Progress and Challenges for Psychiatric Phenotypes in Youth. | Croarkin PE | β | 2023 | β |
| European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment. | Roessner V et al. | β | 2022 | β |
| The Efficacy of Cognitive Behavioral Therapy for Tic Disorder: A Meta-Analysis and a Literature Review. | Shou S et al. | β | 2022 | β |
| A population-based family clustering study of tic-related obsessive-compulsive disorder. | Brander G et al. | β | 2021 | β |
| Bidirectional Behavioral Selection in Mice: A Novel Pre-clinical Approach to Examining Compulsivity. | Mitra S et al. | β | 2021 | β |
| Incompleteness and Disgust Predict Treatment Outcome in Pediatric Obsessive-Compulsive Disorder. | Cervin M et al. | β | 2021 | β |
| Involvement of fear, incompleteness, and disgust during symptoms of pediatric obsessive-compulsive disorder. | Cervin M et al. | β | 2021 | β |
| Moderators of Psychosocial Treatment for Pediatric Obsessive-Compulsive Disorder: Summary and Recommendations for Future Directions. | Kemp J et al. | β | 2021 | β |
| Specialty knowledge and competency standards for pharmacotherapy for pediatric obsessive-compulsive disorder. | Weidle B et al. | β | 2021 | β |
| Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments. | Billnitzer A et al. | β | 2020 | β |
| Ethnicity moderates outcome in family focused treatment for pediatric obsessive compulsive disorder. | Peris TS et al. | β | 2020 | β |
| Psychiatric Diseases in Children and Adolescents. | Cardwell GS et al. | β | 2020 | β |
| The Centrality of Doubting and Checking in the Network Structure of Obsessive-Compulsive Symptom Dimensions in Youth. | Cervin M et al. | β | 2020 | β |
| Challenges in the diagnosis and treatment of pediatric obsessive-compulsive disorder. | Westwell-Roper C et al. | β | 2019 | β |
| Diagnostic Issues in Early-Onset Obsessive-Compulsive Disorder and their Treatment Implications. | Burchi E et al. | β | 2019 | β |
| Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. | Pringsheim T et al. | β | 2019 | β |
| Psychopharmacotherapy of Obsessive-Compulsive Symptoms within the Framework of Tourette Syndrome. | Rothenberger A et al. | β | 2019 | β |
| Treatment of psychiatric disturbances in common hyperkinetic movement disorders. | Berardelli I et al. | β | 2019 | β |
| Attenuation of compulsive-like behavior by fluvoxamine in a non-induced mouse model of obsessive-compulsive disorder. | Mitra S et al. | β | 2018 | β |
| Evidence Base Update of Psychosocial Treatments for Pediatric Obsessive-Compulsive Disorder: Evaluating, Improving, and Transporting What Works. | Freeman J et al. | β | 2018 | β |
| Mediators of Treatment Outcomes for Anxious Children and Adolescents: The Role of Somatic Symptoms. | Hale AE et al. | β | 2018 | β |
| Moderators and predictors of response to cognitive behaviour therapy for pediatric obsessive-compulsive disorder: A systematic review. | Turner C et al. | β | 2018 | β |
| Systematic review of co-occurring OCD and TD: Evidence for a tic-related OCD subtype? | Kloft L et al. | β | 2018 | β |
| Tic-related obsessiveβcompulsive disorder | Pringsheim T et al. | β | 2018 | β |
| Who Benefits from Community Mental Health Care? Using Latent Profile Analysis to Identify Differential Treatment Outcomes for Youth. | Bonadio FT et al. | β | 2018 | β |
| Measurement Issues: The measurement of obsessive compulsive disorder in children and young people in clinical practice. | Bennett SD et al. | β | 2017 | β |
| [New developments in the psychotherapeutic and pharmacological treatment of pediatric obsessivecompulsive disorder]. | Vloet TD et al. | β | 2017 | β |
| Pediatric obsessive-compulsive disorder with tic symptoms: clinical presentation and treatment outcome. | HΓΈjgaard DRMA et al. | β | 2017 | β |
| Tics and Tourette: a clinical, pathophysiological and etiological review. | Dale RC | β | 2017 | β |
| Tic Severity and Treatment in Children: The Effect of Comorbid Attention Deficit Hyperactivity Disorder and Obsessive Compulsive Behaviors. | Pringsheim T | β | 2017 | β |
| Tics in the Pediatric Population: Pragmatic Management. | Ganos C et al. | β | 2017 | β |
| Tourette Syndrome and Chronic Tic Disorders: The Clinical Spectrum Beyond Tics. | Martino D et al. | β | 2017 | β |
| Catechol-O-Methyltransferase Gene Polymorphisms in Specific Obsessive-Compulsive Disorder Patients' Subgroups. | Melo-Felippe FB et al. | β | 2016 | β |
| Predictors of treatment response to group cognitive behavioural therapy for pediatric obsessive-compulsive disorder. | Lavell CH et al. | β | 2016 | β |
| A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION. | McGuire JF et al. | β | 2015 | β |
| Assessment and management of treatment-refractory obsessive-compulsive disorder in children. | Bloch MH et al. | β | 2015 | β |
| Behavioral treatment of social phobia in youth: does parent education training improve the outcome? | Γst LG et al. | β | 2015 | β |
| Cefdinir for recent-onset pediatric neuropsychiatric disorders: a pilot randomized trial. | Murphy TK et al. | β | 2015 | β |
| Cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: Empirical review and clinical recommendations. | Franklin ME et al. | β | 2015 | β |
| Cognitive Behavioral Therapy in Movement Disorders: A Review. | Berardelli I et al. | β | 2015 | β |
| Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial. | Skarphedinsson G et al. | β | 2015 | β |
| Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. | Yu D et al. | β | 2015 | β |
| Family-Based Treatment of Pediatric Obsessive-Compulsive Disorder: Clinical Considerations and Application. | Anderson LM et al. | β | 2015 | β |
| Obsessive-compulsive disorder in children and adolescents. | Krebs G et al. | β | 2015 | β |
| Outcomes of cognitive behaviour therapy for obsessive-compulsive disorder in young people with and without autism spectrum disorders: A case controlled study. | Murray K et al. | β | 2015 | β |
| Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy. | Skarphedinsson G et al. | β | 2015 | β |
| A refresher on Tourette syndrome. | Batterson JR et al. | β | 2014 | β |
| Clinical Features of Tourette Syndrome and Tic Disorders. | Leckman JF et al. | β | 2014 | β |
| Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis. | SΓ‘nchez-Meca J et al. | β | 2014 | β |
| DSM-5 obsessive-compulsive and related disorders: clinical implications of new criteria. | Van Ameringen M et al. | β | 2014 | β |
| Evidence base update for psychosocial treatments for pediatric obsessive-compulsive disorder. | Freeman J et al. | β | 2014 | β |
| Obsessive-compulsive disorder for ICD-11: proposed changes to the diagnostic guidelines and specifiers. | Simpson HB et al. | β | 2014 | β |
| The impact of comorbid body dysmorphic disorder on the response to sequential pharmacological trials for obsessive-compulsive disorder. | Diniz JB et al. | β | 2014 | β |
| Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II. | Conelea CA et al. | β | 2014 | β |
| Tics and Tourette syndrome. | Shaw ZA et al. | β | 2014 | β |
| A cross-sectional study of insight and family accommodation in pediatric obsessive-compulsive disorder. | Bipeta R et al. | β | 2013 | β |
| Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: a naturalistic comparative study. | Masi G et al. | β | 2013 | β |
| Clinical assessment of Tourette syndrome and tic disorders. | Cohen SC et al. | β | 2013 | β |
| Clinical pharmacology of comorbid obsessive-compulsive disorder in Tourette syndrome. | Neri V et al. | β | 2013 | β |
| Dysregulation in pediatric obsessive compulsive disorder. | McGuire JF et al. | β | 2013 | β |
| Nondopaminergic neurotransmission in the pathophysiology of Tourette syndrome. | Udvardi PT et al. | β | 2013 | β |
| Pediatric anxiety disorders: from neuroscience to evidence-based clinical practice. | Salum GA et al. | β | 2013 | β |
| Practice parameter for the assessment and treatment of children and adolescents with tic disorders. | Murphy TK et al. | β | 2013 | β |
| Assessment and medication management of paediatric obsessive-compulsive disorder. | Stewart SE et al. | β | 2012 | β |
| Comorbidity and treatment response in pediatric obsessive-compulsive disorder: a pilot study of group cognitive-behavioral treatment. | Farrell L et al. | β | 2012 | β |
| Error-related negativity and tic history in pediatric obsessive-compulsive disorder. | Hanna GL et al. | β | 2012 | β |
| Obsessive-compulsive disorder: Evidence-based treatments and future directions for research. | Lack CW | β | 2012 | β |
| Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. | β | β | 2012 | β |
| [Psychotherapeutic and pharmacological treatment of pediatric obsessive-compulsive disorder]. | Vloet TD et al. | β | 2012 | β |
| Changes in gray matter volume and white matter microstructure in adolescents with obsessive-compulsive disorder. | Zarei M et al. | β | 2011 | β |
| Cognitive-behavioral therapy for anxiety disorders in youth. | Seligman LD et al. | β | 2011 | β |
| Cognitive-behavioral therapy for obsessive-compulsive disorder in children and adolescents. | Kircanski K et al. | β | 2011 | β |
| Evidence-based pharmacotherapy for pediatric obsessive-compulsive disorder and chronic tic disorders. | De Nadai AS et al. | β | 2011 | β |
| Obsessive-compulsive disorder comorbidity: clinical assessment and therapeutic implications. | Pallanti S et al. | β | 2011 | β |
| Pharmacological management of treatment-resistant obsessive-compulsive disorder. | Abudy A et al. | β | 2011 | β |
| Predictors of early adulthood quality of life in children with obsessive-compulsive disorder. | Palermo SD et al. | β | 2011 | β |
| Psychotherapy and medication management strategies for obsessive-compulsive disorder. | Walsh KH et al. | β | 2011 | β |
| Aripiprazole augmentation in 39 adolescents with medication-resistant obsessive-compulsive disorder. | Masi G et al. | β | 2010 | β |
| Clinical correlates of comorbid obsessive-compulsive disorder and depression in youth. | Canavera KE et al. | β | 2010 | β |
| Correlates of comorbid anxiety and externalizing disorders in childhood obsessive compulsive disorder. | Langley AK et al. | β | 2010 | β |
| Evidence-Based Assessment of Child Obsessive Compulsive Disorder: Recommendations for Clinical Practice and Treatment Research. | Lewin AB et al. | β | 2010 | β |
| Factors associated with poor response in cognitive-behavioral therapy for pediatric obsessive-compulsive disorder. | Storch EA et al. | β | 2010 | β |
| Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. | Leckman JF et al. | β | 2010 | β |
| Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I). | Garcia AM et al. | β | 2010 | β |
| The Genetics of Obsessive-Compulsive Disorder. | Bloch MH et al. | β | 2010 | β |
| Tic suppression: the medical model. | Wu SW et al. | β | 2010 | β |
| Treatment of pediatric obsessive-compulsive disorder: a review. | Mancuso E et al. | β | 2010 | β |
| Treatment-resistant Obsessive-compulsive Disorder in Young People: Assessment and Treatment Strategies. | Krebs G et al. | β | 2010 | β |
| Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors. | Joseph MF et al. | β | 2009 | β |
| Children with obsessive-compulsive disorder: are they just "little adults"? | Kalra SK et al. | β | 2009 | β |
| Clinical course of Tourette syndrome. | Bloch MH et al. | β | 2009 | β |
| Obsessive-compulsive disorder: diagnostic and treatment issues. | Stein DJ et al. | β | 2009 | β |
| Pharmacotherapy in paediatric obsessive-compulsive disorder: a naturalistic, retrospective study. | Masi G et al. | β | 2009 | β |
| Predictors of early adult outcomes in pediatric-onset obsessive-compulsive disorder. | Bloch MH et al. | β | 2009 | β |
| Symptom dimensions and subtypes of obsessive-compulsive disorder: a developmental perspective. | Leckman JF et al. | β | 2009 | β |
| The presence of comorbidity in Tourette syndrome increases the need for pharmacological treatment. | Debes NM et al. | β | 2009 | β |
| Tourette syndrome. | Jimenez-Shahed J | β | 2009 | β |
| Tourette syndrome in children and adolescents: special considerations. | Eapen V et al. | β | 2009 | β |
| [Variability of psychological diagnosis in patients with psychogenic excoriation]. | Alves CJ et al. | β | 2009 | β |
| Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review. | Bloch MH et al. | β | 2008 | β |
| Comorbidity as a predictor and moderator of treatment outcome in youth with anxiety, affective, attention deficit/hyperactivity disorder, and oppositional/conduct disorders. | Ollendick TH et al. | β | 2008 | β |
| Do all obsessive-compulsive disorder subtypes respond to medication? | Grados M et al. | β | 2008 | β |
| Emerging treatments for Tourette's disorder. | Bloch MH | β | 2008 | β |
| Evidence-based psychosocial treatments for child and adolescent obsessive-compulsive disorder. | Barrett PM et al. | β | 2008 | β |
| Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. | Storch EA et al. | β | 2008 | β |
| Optimizing cognitive-behavioral therapy for childhood psychiatric disorders. | Piacentini J | β | 2008 | β |
| Pediatric obsessive-compulsive disorder: management priorities in primary care. | Gilbert AR et al. | β | 2008 | β |
| Predictors of treatment response in pediatric obsessive-compulsive disorder. | Ginsburg GS et al. | β | 2008 | β |
| Cognitive behavioral treatment for young children with obsessive-compulsive disorder. | Freeman JB et al. | β | 2007 | β |